©The Author(s) 2024.
World J Radiol. Dec 28, 2024; 16(12): 794-805
Published online Dec 28, 2024. doi: 10.4329/wjr.v16.i12.794
Published online Dec 28, 2024. doi: 10.4329/wjr.v16.i12.794
Table 4 Subgroup analysis in the goal of research, median (interquartile range)
| Radiomics quality score | Differential diagnosis | Treatment response | Prognosis prediction | Grading or molecular typing | P value |
| Total 36 points | 10 (8–13) | 11 (8–14) | 13 (11–15) | 11 (9–15) | 0 |
| Domain 1: Protocol quality and stability in image and segmentation (0 to 5 points) | 2 (1–2) | 2 (1–2) | 1 (1–2) | 1 (1–2) | 0.006 |
| Image protocol quality (2) | 1 (1–1) | 1 (1–1) | 1 (1–1) | 1 (1–1) | < 0.001 |
| Multiple segmentations (1) | 1 (1–1) | 0 (0–1) | 0 (0–0.75) | 1 (0–1) | < 0.001 |
| Phantom study on all scanners (1) | 0 (0–0) | 0 (0–0) | 0 (0–0) | 0 (0–0) | 0.002 |
| Imaging at multiple time points (1) | 0 (0–0) | 0 (0–0) | 0 (0–0) | 0 (0–0) | 0.36 |
| Domain 2: Feature selection and validation (-8 to 8 points) | 5 (–2–5) | 5 (–2–6) | 5 (5–6) | 5 (5–5) | 0.012 |
| Feature reduction or adjustment for multiple testing (-3 or 3) | 3 (3–3) | 3 (3–3) | 3 (3–3) | 3 (3–3) | 0.601 |
| Validation (-5, 2, 3, 4, or 5) | 2 (–5–2) | 2 (2–2) | 2 (2–3) | 2 (–5–3) | 0.007 |
| Domain 3: Biologic/clinical validation and utility (0 to 6 points) | 2 (0–2) | 1 (1–2) | 1 (1–2) | 2 (0–2) | 0.18 |
| Multivariable analysis with non-radiomics features (1) | 0 (0–0) | 1 (0–1) | 1 (1–1) | 1 (0–1) | < 0.001 |
| Detect and discuss biological correlates (1) | 0 (0–0) | 0 (0–0) | 0 (–0–1) | 0 (0–1) | 0.001 |
| Comparison to ‘gold standard’ (2) | 0 (0–2) | 0 (0–0) | 0 (0–0) | 0 (0–0) | < 0.001 |
| Potential clinical utility (2) | 0 (0–2) | 0 (0–0) | 0 (0–0) | 0 (0–0) | 0.032 |
| Domain 4: Model performance index (0 to 5 points) | 2 (2–2) | 3 (2–4) | 4 (3–5) | 3 (2–4) | < 0.001 |
| Cut-off analyses (1) | 0 (0–1) | 0 (0–1) | 1 (1–1) | 0 (0–1) | < 0.001 |
| Discrimination statistics (2) | 2 (1.5–2) | 2 (2–2) | 2 (1–2) | 2 (1–2) | 0.049 |
| Calibration statistics (2) | 0 (0–0) | 0 (0–2) | 0 (1–2) | 0 (0–2) | < 0.001 |
| Domain 5: High level of evidence (0 to 8 points) | 0 (0–0) | 0 (0–0) | 0 (0–0) | 0 (0–0) | 0.001 |
| Prospective study registered in a trial database (7) | 0 (0–0) | 0 (0–0) | 0 (0–0) | 0 (0–0) | 0.148 |
| Cost-effectiveness analysis (1) | 0 (0–0) | 0 (0–0) | 0 (0–0) | 0 (0–0) | < 0.001 |
| Domain 6: Open science and data (0 to 4 points) | 0 (0–1) | 1 (0–1) | 1 (0–1) | 0 (0–1) | 0.016 |
- Citation: Cao X, Xiong M, Liu Z, Yang J, Kan YB, Zhang LQ, Liu YH, Xie MG, Hu XF. Update report on the quality of gliomas radiomics: An integration of bibliometric and radiomics quality score. World J Radiol 2024; 16(12): 794-805
- URL: https://www.wjgnet.com/1949-8470/full/v16/i12/794.htm
- DOI: https://dx.doi.org/10.4329/wjr.v16.i12.794